Baquiano, Sarah .
HRN: 21-90-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
CEFTAZIDIME 1GM (VIAL)
05/27/2023
06/03/2023
IV
1g
TID
Empiric
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes